Page 364 - 20dynamics of cancer
P. 364

REFERENCES                                                  349

                                H. T., Elliott, R. M., and Collins, F. S. 2000. MLH3: a DNA mismatch repair
                                gene associated with mammalian microsatellite instability. Nature Genetics
                                24:27–35.
                              Liu, S., Dontu, G., and Wicha, M. S. 2005. Mammary stem cells, self-renewal
                                pathways, and carcinogenesis. Breast Cancer Research 7:86–95.
                              Loeb, L. A. 1991. Mutator phenotype may be required for multistage carcino-
                                genesis. Cancer Research 51:3075–3079.
                              Loeb, L. A. 1998. Cancer cells exhibit a mutator phenotype. Advances in Cancer
                                Research 72:25–56.
                              Loeb, L. A., Springgate, C. F., and Battula, N. 1974. Errors in DNA replication as
                                a basis of malignant changes. Cancer Research 34:2311–2321.
                              Lowe, S. W., Cepero, E., and Evan, G. 2004. Intrinsic tumour suppression. Nature
                                432:307–315.
                              Luebeck, E. G., and Moolgavkar, S. H. 2002. Multistage carcinogenesis and the in-
                                cidence of colorectal cancer. Proceedings of the National Academy of Sciences
                                of the United States of America 99:15095–15100.
                              Luria, S. E., and Delbrück, M. 1943. Mutations of bacteria from virus sensitivity
                                to virus resistance. Genetics 28:491–511.
                              Lutz, W. K. 1999. Dose-response relationships in chemical carcinogenesis reflect
                                differences in individual susceptibility. Consequences for cancer risk assess-
                                ment, extrapolation, and prevention. Human and Experimental Toxicology
                                18:707–712.
                              Lynch, H. T., Smyrk, T., and Jass, J. R. 1995. Hereditary nonpolyposis colorectal
                                cancer and colonic adenomas: aggressive adenomas? Seminars in Surgical
                                Oncology 11:406–410.
                              Lynch, M., and Walsh, B. 1998. Genetics and Analysis of Quantitative Traits.
                                Sinauer, Sunderland, MA.
                              MacKenzie, I., and Rous, P. 1940. The experimental disclosure of latent neoplas-
                                tic transformation in tarred skin. Journal of Experimental Medicine 71:391–
                                416.
                              Maley, C. C., Galipeau, P. C., Finley, J. C., Wongsurawat, V. J., Li, X., Sanchez, C. A.,
                                Paulson, T. G., Blount, P. L., Risques, R. A., Rabinovitch, P. S., and Reid, B. J.
                                2006. Genetic clonal diversity predicts progression to esophageal adenocar-
                                cinoma. Nature Genetics 38:468–473.
                              Mao, J. H., Lindsay, K. A., Balmain, A., and Wheldon, T. E. 1998. Stochastic
                                modelling of tumorigenesis in p53 deficient mice. British Journal of Cancer
                                77:243–252.
                              Marsh, D., and Zori, R. 2002. Genetic insights into familial cancers—update and
                                recent discoveries. Cancer Letters 181:125–164.
                              Marshman, E., Booth, C., and Potten, C. S. 2002. The intestinal epithelial stem
                                cell. Bioessays 24:91–98.
                              Mathon, N. F., and Lloyd, A. C. 2001. Cell senescence and cancer. Nature Reviews
                                Cancer 1:203–213.
   359   360   361   362   363   364   365   366   367   368   369